Ketamine Impact on Kidney Health.
Sana Rahman, Samiya Saher, Anurag Raje, Suriya Shanmugar, Isha Gupta
Cureus October 1, 2024 DOI: 10.7759/cureus.70804 via PubMed
Summary
AI-generated from the abstractA 34-year-old woman who used about 5 grams of ketamine daily for two years starting at age 25 developed stage 3 chronic kidney disease and severe urinary complications, including dysuria, flank pain, burning micturition, ketamine-associated cystitis, and renal failure from hydronephrosis. Even after stopping ketamine five years ago, she still needs ureteral stents for recurrent hydronephrosis and ureteral obstruction. Early cessation of ketamine often resolves ulcerative cystitis and ureteral obstruction, but that did not happen in this patient. The case underscores the need to suspect ketamine abuse in young patients with ureteral problems and hydronephrosis, and to pursue early detection, ongoing follow-up, and a comprehensive treatment approach.
Study at a glance
| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | 34-year-old female with chronic ketamine abuse |
| Intervention | bilateral ureteral stents |
| Dose | 5 g daily |
| Keywords | Bilateral hydronephrosis Burning micturition Dysuria Flank pain Hydroureteronephrosis |
| Key finding | Despite discontinuing ketamine five years ago, the patient remains dependent on ureteral stents due to recurrent hydronephrosis and ureteral obstruction, indicating that early cessation did not reverse the uropathy in this case. |
Abstract
Ketamine-induced uropathy (KIU) is a serious consequence of chronic ketamine abuse, presenting with complex renal and urinary symptoms. This study describes a 34-year-old female with a history of chronic ketamine abuse, resulting in stage 3 chronic kidney disease (CKD) and severe urological complications. Despite discontinuing ketamine use five years ago, she remains dependent on ureteral stents due to recurrent hydronephrosis and ureteral obstruction. The patient began using ketamine at the age of 25 years, consuming approximately 5 g daily for two years. By the age of 27 years, she developed dysuria, flank pain, and burning micturition and was later diagnosed with ketamine-associated cystitis and renal failure secondary to hydronephrosis. Initially, bilateral ureteral stents were placed to manage her condition, but she continued to experience worsening symptoms. Although studies suggest that early cessation of ketamine can resolve ulcerative cystitis and ureteral obstruction, this was not observed in our patient. This case highlights the importance of high suspicion for ketamine abuse in young patients presenting with ureteral complications such as hydronephrosis and cystitis-like symptoms. It highlights the need for early detection, ongoing follow-up, and a comprehensive approach involving pharmacological and surgical interventions. Effective management also requires counseling on ketamine discontinuation to prevent further and permanent damage to the urinary system.